Bicycle Therapeutics Ownership | Who Owns Bicycle Therapeutics?
Bicycle Therapeutics Ownership Summary
Bicycle Therapeutics is owned by 53.37% institutional investors, 4.47% insiders, and 42.16% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 15.71% of BCYC shares. Westfield Capital Mgt Co Sm-Cap Gr Eq is the top mutual fund, with 1.47% of its assets in Bicycle Therapeutics shares.
BCYC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Bicycle Therapeutics | 53.37% | 4.47% | 42.16% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 10.89M | 15.71% | $50.51M |
| Fcpm iii services b.v. | 3.47M | 5.01% | $16.09M |
| Armistice capital | 3.40M | 4.90% | $15.77M |
| Long focus capital management | 3.31M | 4.78% | $15.36M |
| Acadian asset management | 1.99M | 2.86% | $7.31M |
| Gsk | 1.53M | 2.19% | $5.63M |
| Renaissance | 1.51M | 2.16% | $5.55M |
| Price t rowe associates inc /md/ | 1.03M | 1.48% | $4.77M |
| Qube research | 840.36K | 1.20% | $3.09M |
| Marshall wace, llp | 835.86K | 1.20% | $3.08M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Aquilo capital management | 171.69K | 2.61% | $1.46M |
| Fcpm iii services b.v. | 3.47M | 2.23% | $16.09M |
| Gsk | 1.53M | 1.13% | $5.63M |
| Rangeley capital | 232.26K | 1.05% | $1.08M |
| Nano cap new millennium growth fund l p | 192.50K | 0.51% | $708.40K |
| Peapod lane capital | 121.11K | 0.45% | $550.21K |
| Long focus capital management | 3.31M | 0.40% | $15.36M |
| Diadema partners lp | 476.42K | 0.38% | $2.21M |
| Birchview capital, lp | 176.43K | 0.38% | $649.27K |
| Baker bros. advisors lp | 10.89M | 0.29% | $50.51M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Long focus capital management | 3.31M | 0.40% | 1.68M |
| Diadema partners lp | 476.42K | 0.38% | 476.42K |
| Armistice capital | 3.40M | 0.28% | 162.00K |
| Peapod lane capital | 121.11K | 0.45% | 121.11K |
| Nano cap new millennium growth fund l p | 192.50K | 0.51% | 112.50K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | - | - | -3.25M |
| Westfield capital management co lp | - | - | -3.02M |
| Siren | - | - | -1.56M |
| Deep track capital, lp | - | - | -1.20M |
| Candriam s.c.a. | - | - | -1.19M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Diadema partners lp | 476.42K | 0.38% | 476.42K | $2.21M |
| Peapod lane capital | 121.11K | 0.45% | 121.11K | $550.21K |
| Tocqueville asset management | 38.50K | 0.00% | 38.50K | $141.68K |
| Gsa capital partners llp | 26.84K | 0.01% | 26.84K | $125.00K |
| Squarepoint ops | 12.07K | - | 12.07K | $44.43K |
Sold Out
| Holder | Change |
|---|---|
| Zurcher kantonalbank (zurich cantonalbank) | -4.00 |
| Northwestern mutual wealth management | -5.00 |
| Rockefeller capital management | -5.00 |
| Mather group, llc. | -5.00 |
| Ronald blue trust | -11.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 112 | 8.74% | 37,256,063 | -0.54% | 53 | 1.85% | 52 | -10.34% | 19 | 18.75% |
| Mar 31, 2026 | 36 | -68.70% | 2,227,370 | -94.31% | 3 | 0.10% | 20 | -64.91% | 6 | -79.31% |
| Dec 31, 2025 | 68 | -33.98% | 13,199,592 | -64.23% | 19 | 0.67% | 32 | -34.69% | 19 | -17.39% |
| Sep 30, 2025 | 94 | -16.07% | 32,600,347 | -18.41% | 47 | 1.41% | 46 | -26.98% | 20 | -4.76% |
| Jun 30, 2025 | 115 | 18.56% | 41,177,900 | -1.34% | 59 | 1.63% | 66 | 53.49% | 21 | -30.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Westfield Capital Mgt Co Sm-Cap Gr Eq | 1.02M | 1.47% | 30.53K |
| Harbor Small Cap Growth Instl | 1.02M | 1.47% | 30.53K |
| Candriam Eqs L Biotech C USD Cap | 825.13K | 1.18% | - |
| T. Rowe Price Health Sciences | 628.42K | 0.90% | - |
| International Biotechnology Ord | 615.83K | 0.88% | - |
| BNP Paribas Health Cr Innovtr Cl Cap | 568.51K | 0.82% | 568.51K |
| Principal U.S. Small Cap Select Equity | 523.30K | 0.75% | -44.50K |
| Principal U.S. Small Cap Equity | 523.30K | 0.75% | -44.50K |
| Principal SmallCap R5 | 511.20K | 0.73% | -4.90K |
| Candriam Global Equities Oncology | 492.11K | 0.71% | 125.18K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 05, 2026 | Perry Jennifer Scott | Chief Operating Officer | Sell | $1.23K |
| Oct 05, 2026 | Perry Jennifer Scott | Chief Operating Officer | Sell | $107.10 |
| Oct 02, 2026 | Swanton Robert Charles | - | Sell | $11.91K |
| Oct 02, 2026 | Skynner Michael | CHIEF SCIENTIFIC OFFICER | Sell | $6.74K |
| Oct 05, 2026 | Skynner Michael | CHIEF SCIENTIFIC OFFICER | Sell | $1.80K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | 14 |
| 2026 Q3 | - | 11 |
| 2026 Q2 | - | 11 |
| 2026 Q1 | - | 13 |
| 2025 Q4 | - | 13 |
BCYC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools